Search

Search Constraints

You searched for: Author/Creator Hamid, Anis

Search Results

1. A polymorphism in the promoter of FRAS1 is a candidate SNP associated with metastatic prostate cancer. Issue 10 (6th May 2021)

2. PSMA and FDG-PET as predictive and prognostic biomarkers in patients given [177Lu]Lu-PSMA-617 versus cabazitaxel for metastatic castration-resistant prostate cancer (TheraP): a biomarker analysis from a randomised, open-label, phase 2 trial. Issue 11 (November 2022)

4. Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study. Issue 1 (26th March 2020)